Pathogenic T‐Cell Recruitment into the Airway in Human Disease
暂无分享,去创建一个
J. Wain | B. Medoff | C. Lilly | A. Luster | Seddon Y. Thomas | L. Ginns | Andrew D Luster | Hui Zhang | A. Banerji | Craig M Lilly | Seddon Y Thomas | John C Wain | Aleena Banerji | Benjamin D Medoff | Leo C Ginns | Hui H. Zhang | JOHN C. WAIN | LEO C. GINNS | ANDREW D. LUSTER
[1] A. Morgan,et al. Mechanisms of T cell migration to the lung , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[2] C. Power,et al. Definition, function and pathophysiological significance of chemokine receptors. , 1998, Trends in pharmacological sciences.
[3] L. Fabbri,et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. , 2001, The Journal of clinical investigation.
[4] E. Miyazaki,et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. , 2002, American journal of respiratory and critical care medicine.
[5] Marshall Hertz,et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] M. Estenne,et al. Bronchiolitis obliterans after human lung transplantation. , 2002, American journal of respiratory and critical care medicine.
[7] C. Agostini,et al. New pathogenetic insights into the sarcoid granuloma. , 2000, Current opinion in rheumatology.
[8] B. Medoff,et al. IFN-γ-Inducible Protein 10 (CXCL10) Contributes to Airway Hyperreactivity and Airway Inflammation in a Mouse Model of Asthma1 , 2002, The Journal of Immunology.
[9] K. Matsushima,et al. Accumulation of CCR4‐expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia , 2003, Allergy.
[10] R. Strieter,et al. Th1 and Th2 responses regulate experimental lung granuloma development. , 1996, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[11] H. Kita,et al. Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. , 1996, The Journal of allergy and clinical immunology.
[12] A. Matas,et al. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] A. Zeevi,et al. Immunological monitoring of lung transplant patients by bronchoalveolar lavage analysis , 1992 .
[14] E. Israel,et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.
[15] C. Agostini,et al. Cells and Molecules Involved in the Development of Sarcoid Granuloma , 1998, Journal of Clinical Immunology.
[16] J. Murray,et al. Release of prostaglandin D2 into human airways during acute antigen challenge. , 1986, The New England journal of medicine.
[17] M. Burdick,et al. Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome1 , 2002, The Journal of Immunology.
[18] James J. Campbell,et al. Expression of Chemokine Receptors by Lung T Cells from Normal and Asthmatic Subjects1 , 2001, The Journal of Immunology.
[19] L. Hassman,et al. Pulmonary Chemokine Expression Is Coordinately Regulated by STAT1, STAT6, and IFN-γ , 2004, The Journal of Immunology.
[20] E. Garrity,et al. Prospective study of functional status and quality of life before and after lung transplantation. , 2000, Chest.
[21] J. Wain,et al. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation , 2005, The Journal of experimental medicine.
[22] T. Moore,et al. Protection from Fluorescein Isothiocyanate-Induced Fibrosis in IL-13-Deficient, but Not IL-4-Deficient, Mice Results from Impaired Collagen Synthesis by Fibroblasts1 , 2004, The Journal of Immunology.
[23] S. Lira,et al. Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.
[24] M. Epstein. Do Mouse Models of Allergic Asthma Mimic Clinical Disease? , 2004, International Archives of Allergy and Immunology.
[25] C. Herrick,et al. To respond or not to respond: T cells in allergic asthma , 2003, Nature Reviews Immunology.
[26] C. Mackay,et al. The role of chemokine receptors in primary, effector, and memory immune responses. , 2000, Annual review of immunology.
[27] Y. Liu,et al. Immune Surveillance and Effector Functions of CCR10+ Skin Homing T Cells , 2002, The Journal of Immunology.
[28] E. Walters,et al. Bronchoalveolar Lavage (BAL) : Critical Evaluation of Techniques. , 2001, Methods in molecular medicine.
[29] R. Rabin,et al. CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.
[30] M. Liu,et al. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. , 2003, The Journal of allergy and clinical immunology.
[31] A. Tager,et al. T-cell trafficking in asthma: lipid mediators grease the way , 2004, Nature Reviews Immunology.
[32] D. Lamb,et al. A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) , 1995, Clinical and experimental immunology.
[33] C. Mackay,et al. T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.
[34] N. Lukacs. Role of chemokines in the pathogenesis of asthma , 2001, Nature Reviews Immunology.
[35] R. Braun,et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.
[36] Alan D. Roberts,et al. Long-Term Maintenance of Virus-Specific Effector Memory CD8+ T Cells in the Lung Airways Depends on Proliferation1 , 2002, The Journal of Immunology.
[37] J. Bradley,et al. The T-cell requirements for allograft rejection* , 1992 .
[38] S. Phan,et al. Dual Roles of IL-4 in Lung Injury and Fibrosis1 , 2003, The Journal of Immunology.
[39] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[40] T. Wynn,et al. Global Gene Expression Profiles During Acute Pathogen-Induced Pulmonary Inflammation Reveal Divergent Roles for Th1 and Th2 Responses in Tissue Repair1 , 2003, The Journal of Immunology.
[41] G. Trinchieri,et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. , 1996, Journal of immunology.
[42] C. Brightling,et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. , 2005, American journal of respiratory and critical care medicine.
[43] F. Re,et al. Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* , 2001, The Journal of Biological Chemistry.
[44] W. Luttmann,et al. Chemokine‐receptor expression on T cells in lung compartments of challenged asthmatic patients , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[45] R. Fairchild,et al. Chemokines: directing leukocyte infiltration into allografts. , 2002, Current opinion in immunology.
[46] S. Bromley,et al. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics , 2005, Nature Immunology.
[47] A. Zeevi,et al. Propagation and characterization of lymphocytes from transplant biopsies. , 1991, Critical reviews in immunology.
[48] S. Kohno,et al. Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis. , 1997, Thorax.
[49] F. Rea,et al. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. , 2001, The American journal of pathology.
[50] L. Cosmi,et al. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease , 2000 .
[51] A. Theofilopoulos,et al. T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis. , 1996, The Journal of clinical investigation.
[52] E. Trulock,et al. Lung and Heart-Lung Transplantation: Overview of Results , 2001, Seminars in respiratory and critical care medicine.
[53] J. Fredberg,et al. Murine models of asthma , 2003, European Respiratory Journal.
[54] M. Taniguchi,et al. A clinical study of idiopathic eosinophilic pneumonia. , 1994, Chest.
[55] J. Grunewald,et al. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis , 2003, Journal of internal medicine.
[56] S. Durham,et al. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge , 2004, European Respiratory Journal.
[57] R. Gerszten,et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment , 2003, Nature Immunology.
[58] V. Kolek,et al. Expression of Macrophage Inflammatory Protein-3β/CCL19 in Pulmonary Sarcoidosis , 2003 .
[59] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[60] S. Orkin,et al. A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.
[61] O. Yoshie,et al. Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression , 2002, The Journal of Immunology.
[62] G. Patterson,et al. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation , 1995 .
[63] G. Berry,et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. , 1996, The Annals of thoracic surgery.
[64] B. Beghé,et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.
[65] S. Targan,et al. The Role of Thymus-Expressed Chemokine and Its Receptor CCR9 on Lymphocytes in the Regional Specialization of the Mucosal Immune System1 , 2000, The Journal of Immunology.
[66] S. Lira,et al. Attenuation of Allergen-Induced Responses in CCR6−/− Mice Is Dependent upon Altered Pulmonary T Lymphocyte Activation , 2005, The Journal of Immunology.
[67] S. Kunkel,et al. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] J. Lafitte,et al. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. , 2001, The Journal of allergy and clinical immunology.
[69] Tong-Yuan Yang,et al. Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.
[70] P. Libby,et al. Differential Expression of the IFN-γ-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell α Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection1 , 2002, The Journal of Immunology.
[71] Eric J. Kunkel,et al. CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.
[72] H. Mukae,et al. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. , 2000, The Journal of allergy and clinical immunology.
[73] R. Puri,et al. Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells 1 , 2003, The Journal of Immunology.
[74] D. D'Ambrosio,et al. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. , 2001, American journal of respiratory and critical care medicine.
[75] M. Baggiolini,et al. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.
[76] E. Chi,et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma , 1996, The Journal of experimental medicine.
[77] J. Virchow,et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. , 1995, American journal of respiratory and critical care medicine.
[78] C. Mackay,et al. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.
[79] B. Damaj,et al. Expression and regulation of chemokine receptors in human natural killer cells. , 2001, Blood.
[80] C. Mackay,et al. Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.
[81] A. Wade,et al. Lung transplantation and life extension in children with cystic fibrosis , 1999, The Lancet.
[82] C. Caux,et al. Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.
[83] L. Cauley,et al. Antiviral memory T-cell responses in the lung. , 2002, Microbes and infection.
[84] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[85] R. Crystal,et al. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. , 1985, The Journal of clinical investigation.
[86] M. Chilosi,et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. , 1998, Journal of immunology.
[87] Y. Kaneda,et al. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[88] A. Waaga,et al. Mechanisms of chronic rejection. , 2000, Current opinion in immunology.
[89] B. Griffith,et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. , 1990, Transplantation.
[90] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[91] T. Out,et al. Influx of Neutrophils into the Airway Lumen at 4 h after Segmental Allergen Challenge in Asthma , 1999, International Archives of Allergy and Immunology.
[92] E. Kunkel,et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. , 2001, The Journal of clinical investigation.
[93] Stuart B. Goodman,et al. Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.
[94] James J. Campbell,et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells , 1999, Nature.
[95] Sharon Engel,et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.
[96] S. Tullius,et al. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. , 1995, Transplantation.
[97] H. Mukae,et al. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease. , 2000, The European respiratory journal.
[98] E. Kriehuber,et al. Macrophage Inflammatory Protein 3α Is Involved in the Constitutive Trafficking of Epidermal Langerhans Cells , 1999, The Journal of experimental medicine.
[99] D. Adams,et al. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. , 2001, Transplantation.
[100] A. Tager,et al. Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.
[101] M. Fujimura,et al. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. , 1998, Respiratory medicine.
[102] M. Essink‐bot,et al. The effect of lung transplantation on health-related quality of life: a longitudinal study. , 1998, Chest.